Yi Jiahong, Guo Hui, Jiang Chang, Duan Junyi, Xue Ju, Zhao Yue, He Wenzhuo, Xia Liangping
Department of VIP Region, Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Front Endocrinol (Lausanne). 2024 Dec 12;15:1462591. doi: 10.3389/fendo.2024.1462591. eCollection 2024.
It is necessary to find latent indicators to predict the survival of alcohol-associated liver disease (ALD) patients. Leukocyte telomere length (LTL) was regarded as an indicator of prognosis in several diseases. However, the relationships between LTL and survival as well as cause-specific mortality in ALD patients were still unknown.
This study aimed at exploring the underlying link between LTL and the risk of mortality in patients with ALD.
The LTL and survival data were gathered from the National Health and Nutrition Examination Survey (NHANES) 1999-2002. The connection between LTL and mortality was assessed by Cox regression models and stratified analyses. The non-linear relationship was explored by restricted cubic spline (RCS) analysis. Sensitivity analyses were used to evaluate the robustness of our findings.
LTL was a negative factor for all-cause mortality (all -value < 0.05). The risk of cardiovascular disease (CVD)-related death was decreased in Q3 ( < 0.001) and Q4 levels of LTL ( < 0.001) compared with the Q1 group. Shorter LTL resulted in higher cancer-caused mortality ( = 0.03) in the Q2 group. Longer LTL improved survival especially for elder patients ( for trend < 0.001) or men ( for trend = 0.001). Moreover, there were L-shaped correlations between LTL and all-cause mortality ( for non-linearity = 0.02), as well as cancer-related mortality ( for non-linearity < 0.001). Four sensitivity analyses proved the robustness of our findings.
Our research found that longer LTL improved survival in patients with ALD and decreased CVD and cancer-related mortality. LTL decreased all-cause mortality especially for patients older than 65 years or men. LTL might be a useful biomarker for prognosis among patients with ALD. More prospective studies are needed to assess the relevance between LTL and mortality and explore the underlying mechanisms between them.
有必要寻找潜在指标来预测酒精性肝病(ALD)患者的生存情况。白细胞端粒长度(LTL)在多种疾病中被视为预后指标。然而,LTL与ALD患者生存及特定病因死亡率之间的关系仍不明确。
本研究旨在探讨LTL与ALD患者死亡风险之间的潜在联系。
从1999 - 2002年美国国家健康与营养检查调查(NHANES)中收集LTL和生存数据。通过Cox回归模型和分层分析评估LTL与死亡率之间的关联。采用受限立方样条(RCS)分析探索非线性关系。使用敏感性分析评估研究结果的稳健性。
LTL是全因死亡率的负性因素(所有P值<0.05)。与Q1组相比,LTL处于Q3(P<0.001)和Q4水平时,心血管疾病(CVD)相关死亡风险降低。LTL较短导致Q2组癌症所致死亡率较高(P = 0.03)。较长的LTL可改善生存,尤其是老年患者(趋势P<0.001)或男性(趋势P = 0.001)。此外,LTL与全因死亡率(非线性P = 0.02)以及癌症相关死亡率(非线性P<0.001)之间存在L形相关性。四项敏感性分析证明了研究结果的稳健性。
我们的研究发现,较长的LTL可改善ALD患者的生存情况,并降低CVD和癌症相关死亡率。LTL降低全因死亡率,尤其是65岁以上患者或男性。LTL可能是ALD患者预后的有用生物标志物。需要更多前瞻性研究来评估LTL与死亡率之间的相关性,并探索它们之间的潜在机制。